Yunfeng Cheng: Clinical Trials

3 trials sponsored by Yunfeng Cheng, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting. 3 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable3Recruiting 3

Follow Yunfeng Cheng: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Efficacy and Safety of HCQ Plus TPO-RA in ANA Positive ITP
Hydroxychloroquine Oral Tablet, Eltrombopag - Immune Thrombocytopenia With Positive ANA Antibodies
Not applicableRecruitingYunfeng Cheng1262024-07-012024-06-28
The Efficacy and Safety of HCQ Plus Pred in ANA Positive ITP
Hydroxychloroquine Oral Tablet, Prednisone tablet - Immune Thrombocytopenia With Positive ANA Antibodies
Not applicableRecruitingYunfeng Cheng1292024-04-242024-06-28
The Efficacy and Safety of HCQ Plus DEX in ANA Positive ITP
Hydroxychloroquine Oral Tablet, Dexamethasone oral - Immune Thrombocytopenia With Positive ANA Antibodies
Not applicableRecruitingYunfeng Cheng1292024-04-242024-06-28

Interventions

Hydroxychloroquine (3)  ·  Dexamethasone (1)  ·  Prednisone (1)  ·  eltrombopag (1)

Countries

China (3)  ·  Hong Kong (3)  ·  Macau (3)

Results publications

PMID 24254965, PMID 28416506, PMID 35288899